Project Details


This is a multi-center, pragmatic, prospective, randomized,
open-label, and blinded end-point assessment (PROBE)
clinical trial. A total of 1,456 patients presenting within 7 days
of a spontaneous lobar ICH while taking statins will be
randomized to one of two treatment strategies:
discontinuation vs. continuation (restarting) of statin therapy
(using the same agent and dose that they were using at ICH
StatusNot started


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.